Related Experiment Video
Updated: Mar 24, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
A lethal case of the dapsone hypersensitivity syndrome involving the myocardium
R M Hoogeveen1, T van der Bom, H H de Boer
1Department of Infectious disease, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Abstract:
In the Netherlands dapsone is used for the treatment of dermatitis herpetiformis, leprosy and Pneumocystis jiroveci pneumonia and prophylaxis in case of cotrimoxazole allergy. An idiosyncratic drug reaction, known as the dapsone hypersensitivity syndrome (DHS), appears in about 0.5-3.6% of persons treated with dapsone. DHS can be associated with fever, rash and systemic involvement. We present a 35-year-old woman who developed severe DHS seven weeks after starting dapsone. Six weeks after being discharged in a good clinical condition she died from fulminant myocarditis, 11 weeks after the first DHS symptoms and the discontinuation of dapsone.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Diphtheria
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Rheumatic Heart Disease I: Introduction

